After signing off the result it is automatically sent to thelaboratory data system LIS where it is archived
After signing off the result, it is automatically sent to thelaboratory data system (LIS), where it is archived together with thepatient record. The analyzer performs apreliminary WBC Differential and RBC Characterization, and providesfunctionality for platelet estimation. Formore information, visit ’s share is listed on First North Premier at the OMX StockholmStock Exchange. CellaVision is traded under the ticker symbol CEVI andthe ISIN code SE0000683484 The company’s Certified Advisor is RemiumAB. Features and Benefits – CellaVision(R) DM1200CellaVision DM1200 automates the work that is traditionally done bylaboratory personnel using microscopes.
The company also hassubsidiaries in Florida, USA, Toronto, Canada and Yokohama, Japan. Thecompany has a core competence in development of software and hardware forautomatic image analysis of cells and cell changes for applications inhealth and medical care. The company develops and markets systems forautomatic differentials of white blood cells and red morphology, andsoftware for education and quality assurance of differentials. Thecompany’s associates have expertise in advanced imaging analysis,artificial intelligence, and automated microscopy.The company headquarters are in Lund, Sweden.
The hardware is prepared for body fluid analysis.The blood application is included in the CellaVision DM1200 and will becommercially available in Europe by the end of July. The application forbody fluids is sold as a separate product and is intended to be releasedby the end of the year. The company is planning to apply for productregistrations in Canada, the US and Japan.CellaVision’s current range of products includes the analyzersCellaVision(R) DM96 and CellaVision(R) DM8 as well as software for remoteaccess, and proficiency testing and education – CellaVision(R) RemoteReview Software and CellaVision(R) Competency Software. “We see asubstantial potential for this product on the European and North Americanmarkets as trends indicate that not only the large but also themedium-sized laboratories aim to streamline their analytical flow,” saysYvonne Martensson, CEO of CellaVision. E-mail: About CellaVisionCellaVision AB develops, markets, and sells market leading image analysisbased systems for routine analysis of blood and other body fluids. For more details, please visit more product information and a product picture, please seebelow.For more information, please contact:Yvonne Martensson, CEO, CellaVision ABPhone: +46 708 33 77 82. All of theproducts are compatible with each other and can be part of the samehospital network.CellaVision DM1200 will be presented at the AACC in Chicago, USA, on the19-23 of July 2009 in CellaVision’s and Sysmex Amercia’s show cases (238and 2025 respectively).
The convention is expected to draw 20,000international visitors. China would overtake Japan as the world’s second-biggesteconomy after the United States late this year or sometime nextyear, said Deng, who forecast China’s economy to grow 8.3 percentthis year and 10.9 percent in 2010. “This analyzer is powerful andflexible, and is intended to serve as a platform for future applications,giving CellaVision yet more of a competitive edge.”The CellaVision DM1200 replaces manual microscopy for analysis of bloodsamples and is aimed at clinical chemistry laboratories wishing toautomate their manual differentials, making their analytical flow moreefficient. COMPETITIVE LANDSCAPETotal Companies Profiled: 58 (including Divisions/Subsidiaries – 64)To order this report:Reportlinker Adds Contactless Smart Cards http:// market research reports here!ReportlinkerNicolas: US: (805)-652-2626Intl: +1 805-652-2626 Copyright Business Wire 2009.
LUND, SWEDEN, Jul 16 (MARKET WIRE) — CellaVision AB (publ), which develops and sells digital morphologyproducts for the routine analysis of blood and other body fluids,presents their new analyzer CellaVision(R) DM1200 at the internationallab exposition AACC Annual Meeting & Clinical Lab Expo in Chicago, USA,on July 19-23. The product is commercially available in Europe and willbe available in North America and Japan when CellaVision has receivedclearance from the respective countries’ authorities. (The Netherlands)II-62 NOVACARD INFORMATIONSSYSTEME GmbH (Germany) II-62 NXP Semiconductors (The Netherlands) II-62 Oberthur Card Systems SA (France) II-63 On Track Innovations Ltd (Israel) II-63 Sagem Orga GmbH (Germany) II-63 Samsung Electronics Co., Ltd (South Korea) II-64 Silicon Storage Technology, Inc (US) II-64 Sitronics JSC (Russia) II-64 Sony Corporation (Japan) II-65 STMicroelectronics (Switzerland) II-65 Incard SpA (Part of STMicroelectronics) (Italy)II-65 Toppan Printing Co., Ltd (Japan) II-66 Watchdata System Co Ltd (China) II-66 Zetes Industries (Belgium) II-66 11. (The Netherlands)II-59 General Information Systems Ltd (UK) II-59 Giesecke & Devrient GmbH (Germany)II-60 HID Global Corporation (US) II-60 Infineon Technologies AG (Germany)II-60 Inside Contactless (France) II-61 International Business Machines Corporation (US)II-61 IRIS Corporation Berhad (Malaysia)II-61 Micromodule Pte Ltd (Singapore) II-61 NBS Technologies (Canada) II-62 NedCard B.V. FOCUS ON SELECT KEY PLAYERS II-56 ActivIdentity Corporation (US)II-56 Advanced Card Systems Ltd (Hong Kong) II-56 American Microdevice Manufacturing, Inc. (US) II-56 ASK (France)II-57 Austria Card GmbH (Austria) II-57 CardLogix Corporation (US) II-57 CPI Card Group (US) II-58 Eastcompeace Smart Card Co., Ltd (China) II-58 FNMT-RCM (Spain)II-58 Fujitsu Microelectronics Limited (Japan) II-58 Gemalto N.V. SMART CARDS – COMPETITIVE SCENARIO II-31 Potential Favors Growth in the Intensely Competitive MarketII-31 Table 1: Leading Players in the World Smart Card Market (2007): Percentage Breakdown of Shipments for Gemalto NV, Giesecke & Devrient GmbH, Oberthur Card Systems, Sagem Orga, Incard SpA, and Others (includes corresponding Graph/Chart) II-31 Leading Smart Card Players – An Analysis of Competitor Strategies II-32 7.